GEV vs MRK: Which Is the Better Buy?
Side-by-side comparison of GE Vernova Inc. and Merck & Co., Inc. โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
GE Vernova Inc. ยท Industrials
$951.82
+35.4% upside to fair value
Med Conviction
Grade B
High Quality
VS
Merck & Co., Inc. ยท Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
GEV has more upside to fair value
(+35.4%).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
GEV |
MRK |
| Current Price |
$951.82 |
$147.17 |
| Fair Value Estimate |
$1,288.67 |
$141.07 |
| Upside to Fair Value |
+35.4%
|
-4.1%
|
| Market Cap |
$253.5B |
$363.5B |
| Forward P/E |
โ
|
โ
|
| EV / EBITDA |
28.2x
|
29.6x
|
| Price / Sales |
6.1x
|
5.5x
|
| Price / FCF |
20.5x
|
22.6x
|
| Revenue Growth YoY |
+21.9%
|
+5.1%
|
| Gross Margin |
20.2%
|
75.4%
|
| Operating Margin |
4.4%
|
16.7%
|
| Return on Equity |
83.4%
|
6.6%
|
| Dividend Yield |
0.18% |
2.31% |
| FCF Yield |
4.88%
|
4.42%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
GE Vernova is an energy equipment and infrastructure enterprise spanning Power (gas, nuclear, hydro, steam), Wind (offshore and onshore turbines), and Electrification (grid, power conversion, solar and storage), with 78,000 employees and a Cambridge, Massachusetts headquarters. The business quality is high on the strength of an installed base that generates roughly 25% of the world's electricity,โฆ
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely higโฆ
Accumulation Zones
| Metric |
GEV |
MRK |
| Zone Low |
$966.50 |
$105.80 |
| Zone High |
$1,095.37 |
$119.91 |
| In Buy Zone? |
Yes
|
No
|